CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer’s disease
Science Advances · 18.07.2025 · 11 (29)
DOI: 10.1126/sciadv.adv1492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 18.07.2025. Verfasst von Xin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurogenesis, Signal Transduction, Chitinase-3-Like Protein 1. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
CHI3L1/YKL-40 is an astrocyte-secreted glycoprotein recognized as a biomarker of CNS inflammation and implicated in Alzheimer’s disease (AD) cognitive decline. However, its precise pathological role remains unclear. Here, we investigate CHI3L1’s function and its therapeutic potential in AD using both human induced pluripotent stem cell–derived neurogenesis models and in vivo conditional AD mouse models, with astrocyte-specific CHI3L1 knockout, alongside 5XFAD mice. Our data reveal that CHI3L1 secretion by astrocytes impairs neural stem cell (NSC) proliferation and neuronal differentiation by activating the CRTH2 receptor, which triggers a downstream cascade involving IKKβ, S6K1, and S6 phosphorylation. This cascade depletes the NSC pool in the hippocampus, thereby reducing neurogenesis. Notably, targeting astrocytic CHI3L1 or blocking CRTH2 and its downstream effectors substantially restored neurogenesis and cognitive function, highlighting CHI3L1 as a promising therapeutic target for AD and related neurodegenerative disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI, USA.
- Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Jinan, Shandong, Ch…
- Center for Translational Neuroscience, Carney Institute for Brain Science, Brown University, Providence, RI, USA.
ORCID-Profile: Xin Yang, Wei Jiang, Chun Geun Lee, Jack A Elias, Changyong Tang, Yu-Wen Alvin Huang
Förderung
- NIA NIH HHS
Zitieren
APA
Yang, X., Jiang, W., Li, Y., Lee, C. G., Elias, J. A., Tang, C., & Huang, Y. A. (2025). CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer’s disease. Science Advances, 11(29). https://doi.org/10.1126/sciadv.adv1492
Vancouver
Yang X, Jiang W, Li Y, Lee CG, Elias JA, Tang C, et al. CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer’s disease. Science Advances. 2025;11(29). doi:10.1126/sciadv.adv1492
BibTeX
@article{Yang2025,
author = {Yang, Xin and Jiang, Wei and Li, Yuhan and Lee, Chun Geun and Elias, Jack A and Tang, Changyong and Huang, Yu-Wen Alvin},
title = {CHI3L1/YKL-40 signaling inhibits neurogenesis in models of Alzheimer’s disease},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {29},
doi = {10.1126/sciadv.adv1492}
}
EUVIMED